Hepatic Metastases Unknown Status Phase 3 Trials for Capecitabine (DB01101)

Also known as: Metastases to liver / Liver Metastases / Metastatic neoplasm of liver / Cancer of liver, secondary / Metastasis to liver / Malignant neoplasm of liver, specified as secondary

IndicationStatusPhase
DBCOND0032606 (Hepatic Metastases)Unknown Status3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00156975Oxaliplatin and Capecitabine Versus Follow-up After Resection of Colorectal Liver MetastasesTreatment